AI Summary
This article discusses how the activation of kappa opioid receptors can lead to the epigenetic silencing of brain-derived neurotropic factor (BDNF) through HDAC5 in depression. This research has implications for understanding the molecular mechanisms involved in depression and may lead to the development of new treatment approaches targeting these pathways.